SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE

被引:0
|
作者
Kramer, Kim [1 ]
Kushner, Brian [1 ]
Modak, Shakeel [1 ]
Pandit-Taskar, Neeta [1 ]
Tomlinson, Ursula [1 ]
Donzelli, Maria [1 ]
Wolden, Suzanne [1 ]
Zanzonico, Pat [1 ]
Humm, John [1 ]
Haque, Sophia [1 ]
Souweidane, Mark [1 ,2 ]
Greenfield, Jeffrey [3 ]
Basu, Ellen [1 ]
Roberts, Stephen [1 ]
Carrasquillo, Jorge [1 ]
Lewis, Jason [1 ]
Lyashchenko, Serge [1 ]
Larson, Steven [1 ]
Cheung, Nai-Kong [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PDCT-04
引用
收藏
页码:184 / 184
页数:1
相关论文
共 11 条
  • [11] DB-1419, a first-in-class bispecific ADC targeting B7-H3 and PD-L1 with a DNA topoisomerase I inhibitor, exhibits promising efficacy and safety in preclinical models
    Li, C.
    Yao, J.
    Yang, J.
    Li, Z.
    Shi, R.
    Qiu, Y.
    Hua, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S72 - S72